- Investing Ideas
- Australian Healthcare Undervalued over 20% based on DCF
Australian Healthcare Undervalued over 20% based on DCF
Results
4
Companies which are undervalued more than 20% based on the Discounted Cash Flow valuation.
4 companies
Ramsay Health Care
Market Cap: AU$8.4b
Owns and operates hospitals in Australia and internationally.
RHC
AU$36.62
7D
-1.3%
1Y
-2.7%
Ansell
Market Cap: AU$3.9b
Designs, sources, develops, manufactures, distributes, and sells hand and body protection solutions in the Asia Pacific, Europe, the Middle East, Africa, Latin America, the Caribbean, and North America.
ANN
AU$27.71
7D
-0.5%
1Y
-11.0%
PolyNovo
Market Cap: AU$728.8m
Designs, manufactures, and sells biodegradable medical devices in Australia, New Zealand, the United States, the United Kingdom, Ireland, Singapore, India, and Hong Kong.
PNV
AU$1.06
7D
-13.5%
1Y
-19.5%
SomnoMed
Market Cap: AU$131.4m
SomnoMed Limited, together with its subsidiaries, produce and sells devices for the oral treatment of sleep related disorders in the Asia Pacific region, North America, and Europe.
SOM
AU$0.60
7D
5.3%
1Y
-4.8%